Objective
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
Management group
Schroder Investment Management
Launch date
06/05/1994
Domicile
United Kingdom
Fund manager
Ailsa Craig, Marek Poszepczynski
Dividend frequency
Semi-Annually
Wind-up provisions
The Association Articles of the company provide for Directors to put forward a proposal for the continuation of the company at the AGM at two-yearly intervals. The upcoming continuation vote is scheduled for the December 2025 AGM.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
260.97 327.21 702.00 786.68 -10.76 8 4.02 Jul, Dec 1.4 (31/08/2023)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
25/07/2024 23/08/2024 14.500 No 2024
21/12/2023 26/01/2024 13.900 No 2024
27/07/2023 25/08/2023 14.200 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
International Biotechnology Share price total return 14.7 7.4 31.1 228.1
Biotechnology & Healthcare AIC sector Share price total return 9.3 -12.3 8.2 136.6
Scroll

Share structure

Number of shares
37,174,910

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 55,654 1,195,904 14,233,822 83,580,148
Average N/A 48,737 56,336 66,177
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.39 7.88 90.43 574.62
Average N/A 0.32 0.36 0.46
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB0004559349 IBT GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 30/06/2024

Investment % of total assets
Sv Bcof 5.4
Sv Fund Vi Investment 5.0
Vera Therapeutics Inc Class A 4.8
Intra-Cellular Therapies Inc 4.4
Biomarin Pharmaceutical Inc 4.3
Cytokinetics Inc 4.2
Supernus Pharmaceuticals Inc 4.1
Insmed Inc 4.0
BeiGene Ltd ADR 3.7
Scb Sholo211123b 24-Jun-2024 6.46% 24-Jul-2024 -13.7

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.